Literature DB >> 9368943

Trends in conceptions before and after the 1995 pill scare.

R Wood, B Botting, K Dunnell.   

Abstract

On 18 October 1995, the Committee on Safety of Medicines issued a warning that seven brands of the contraceptive pill (containing 'new generation' progestogens) carried a relatively higher risk of thrombosis (the formation of a blood clot in a vein). This warning received much attention from the media. Family planning services and others working in public health raised concerns that the pill scare would result in an increase in unplanned pregnancies. This article uses national conception statistics to show trends before and after October 1995.

Entities:  

Keywords:  Abortion Rate--changes; Abortion, Induced; Age Factors; Behavior; Contraception; Contraceptive Methods--side effects; Demographic Factors; Developed Countries; Emotions; England; Europe; Family Planning; Fear; Fertility; Fertility Control, Postconception; Fertility Measurements; Northern Europe; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Population; Population Characteristics; Population Dynamics; Pregnancy Rate--changes; Psychological Factors; Research Methodology; Research Report; Statistical Studies; Studies; United Kingdom; Wales

Mesh:

Substances:

Year:  1997        PMID: 9368943

Source DB:  PubMed          Journal:  Popul Trends        ISSN: 0307-4463


  7 in total

1.  Sexual health of teenagers. Trends should be examined over longer period.

Authors:  A Noone; J Chalmers; M Hollinsworth; K McIntyre; B Cant
Journal:  BMJ       Date:  1999-11-20

Review 2.  Impact of safety-related regulatory action on clinical practice: a systematic review.

Authors:  Sigrid Piening; Flora M Haaijer-Ruskamp; Jonie T N de Vries; Menno E van der Elst; Pieter A de Graeff; Sabine M J M Straus; Peter G M Mol
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

3.  Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysis.

Authors:  Christopher J Weatherburn; Bruce Guthrie; Tobias Dreischulte; Daniel R Morales
Journal:  Br J Clin Pharmacol       Date:  2019-12-16       Impact factor: 4.335

Review 4.  Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.

Authors:  Stacie B Dusetzina; Ashley S Higashi; E Ray Dorsey; Rena Conti; Haiden A Huskamp; Shu Zhu; Craig F Garfield; G Caleb Alexander
Journal:  Med Care       Date:  2012-06       Impact factor: 2.983

5.  Trends in teenage pregnancy in England and Wales: how can we explain them?

Authors:  K Wellings; R Kane
Journal:  J R Soc Med       Date:  1999-06       Impact factor: 5.344

6.  Impact of FDA black box advisory on antipsychotic medication use.

Authors:  E Ray Dorsey; Atonu Rabbani; Sarah A Gallagher; Rena M Conti; G Caleb Alexander
Journal:  Arch Intern Med       Date:  2010-01-11

7.  Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.

Authors:  Thomas Goedecke; Daniel R Morales; Alexandra Pacurariu; Xavier Kurz
Journal:  Br J Clin Pharmacol       Date:  2017-12-20       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.